Skip to content
Medical & Historical

What Was the Infected Blood Scandal?

For decades, people across the UK were infected with HIV, hepatitis B and hepatitis C through contaminated blood and blood products provided through the NHS. The public inquiry that examined what happened found serious and largely avoidable failures across blood services, treatment, government and healthcare.

By The Unheard Voice · Sep 21, 2026

The infected blood scandal is one of the gravest failures in the history of the NHS.

Across the UK, people who relied on blood transfusions or blood products were exposed to viruses including HIV, hepatitis B and hepatitis C. Many became seriously ill. Many died. Families were left caring for loved ones, losing parents, partners and children, and living for decades with consequences they had never been warned about.

The Infected Blood Inquiry, led by Sir Brian Langstaff, examined what happened over eight years and published its final report on 20 May 2024. The Inquiry investigated the circumstances that led to people being given infected blood or blood products by the UK’s National Health Services, particularly during the period from the 1970s through to the 1990s.

The Government has since described the findings as a catalogue of failures at systemic, collective and individual level. Its formal response states that more than 3,000 deaths are attributable to infected blood, blood products and tissue, and that the Inquiry found those deaths and much of the wider harm were largely avoidable.

How did people become infected?

There were different routes.

Some people with haemophilia and other bleeding disorders were treated with clotting-factor concentrates made from pooled human plasma. Because plasma from very large numbers of donors could be combined into a single batch, contamination from one or more donors could expose many recipients.

Other people were infected following blood transfusions given during surgery, childbirth, cancer treatment, accidents or treatment for other conditions.

The Inquiry examined blood services, blood products, clinical practice, haemophilia centres, government decision-making and the response to known risks.

This matters because the scandal was never limited to one type of patient or one treatment.

It involved people with bleeding disorders, people receiving transfusions and, in some circumstances, people infected indirectly through someone who had themselves been infected.

HIV and hepatitis

The infections involved were not all the same.

HIV can damage the immune system and, without effective treatment, can progress to AIDS.

Hepatitis B and hepatitis C affect the liver. Chronic infection can lead to serious long-term illness, including cirrhosis and liver cancer.

For many families, the medical consequences were compounded by stigma, fear and secrecy.

People living with HIV in the 1980s and 1990s often faced extreme discrimination. Some families concealed diagnoses because they feared how schools, employers, neighbours or even healthcare professionals might react.

Others spent years not knowing they had hepatitis because testing was not always available at the time they were exposed.

What did the Inquiry find?

The significance of the final Inquiry report is that it did not describe the scandal simply as an unavoidable tragedy.

It examined what institutions knew, when risks became apparent, how decisions were made and how patients were treated.

Its final report covers the experiences of infected and affected people, the development of medical knowledge, blood services, blood products, government responses to risk, haemophilia centres, pharmaceutical companies, transfusion practice and many other parts of the system.

The Government later acknowledged decades of suffering and injustice and apologised on behalf of the state.

That distinction is important.

The scandal is not simply that contaminated blood existed.

It is also about how risks were handled, whether patients were properly informed, what happened after infections became known, how records and evidence were managed, and why recognition and redress took so long.

The damage went far beyond the infected person

The term infected blood scandal can make it sound as though the harm ended with the person who received the blood or blood product.

It did not.

Partners became carers.

Children grew up around serious illness and bereavement.

Parents watched children become unwell.

Families lost income, careers, homes and opportunities.

Some people experienced stigma and social isolation.

Others spent decades campaigning for answers while also trying to care for relatives or deal with their own health.

That is why both official compensation policy and the Inquiry distinguish between infected people and affected people. Current compensation arrangements recognise that some family members and carers also suffered harm through their relationship with an infected person.

Why did it take so long?

The infected blood scandal unfolded over decades.

Campaigners, families and survivors repeatedly challenged official accounts, sought access to records and pushed for a full public inquiry.

By the time the Inquiry finally reported, many of the people most directly affected had already died.

That delay is one of the reasons compensation, recognition and accountability remain such significant issues today.

What happened after the Inquiry?

Following the Inquiry, the Government established a UK-wide compensation scheme.

The Victims and Prisoners Act 2024 provided the legal basis for the Infected Blood Compensation Authority, known as IBCA. IBCA now administers compensation for eligible infected and affected people and for estates of some people who have died.

The compensation scheme is now established in law and continues to develop through regulations and government policy.

Compensation, however, does not erase what happened.

Nor does it answer every question families continue to raise about recognition, evidence, bereavement, deceased claims, historic medical records or the implementation of recommendations.

Why the story still matters

The infected blood scandal is sometimes spoken about as history.

For thousands of families, it is not.

People are still living with the consequences of infection.

Families are still dealing with bereavement.

Claims are still being assessed.

Evidence is still being gathered.

And debates about compensation, recognition and accountability are still continuing.

That is why understanding the scandal means looking beyond statistics.

Behind every infection was a person.

Behind many of those people was a family.

And behind the Inquiry’s millions of pages of evidence are lives that were permanently changed by treatment people believed they could trust.

These were not simply patients in a historical medical disaster.

They were people whose lives, families and futures were altered by a scandal that lasted for generations.

Last updated: September 2026

Next: Who was affected by the infected blood scandal? →

Sources